Chronic kidney disease: a clinical model of premature aging.
about
On the occasion of world kidney day 2016; work together to better protect the kidneyMacrophage Migration Inhibitory Factor in Clinical Kidney DiseaseKlotho, stem cells, and agingCalcium regulation and bone mineral metabolism in elderly patients with chronic kidney diseaseAlkaline phosphatase: a novel treatment target for cardiovascular disease in CKD.The systemic nature of CKD.Mortality is associated with inflammation, anemia, specific diseases and treatments, and molecular markersIs chronic kidney disease-mineral and bone disorder associated with the presence of endothelial progenitor cells with a calcifying phenotype?Comparative associations of muscle mass and muscle strength with mortality in dialysis patients.Aldosterone activates transcription factor Nrf2 in kidney cells both in vitro and in vivoMolecular basis of Klotho: from gene to function in agingFrailty and mortality in dialysis: evaluation of a clinical frailty scale.Calculating the Rate of Senescence From Mortality Data: An Analysis of Data From the ERA-EDTA Registry.The Inflammatory Transcription Factors NFκB, STAT1 and STAT3 Drive Age-Associated Transcriptional Changes in the Human KidneyMenopausal symptoms in women with chronic kidney disease.α-Klotho Expression in Human Tissues.Calcification Propensity and Survival among Renal Transplant Recipients.Accelerated ageing and renal dysfunction links lower socioeconomic status and dietary phosphate intakemTOR Inhibition: From Aging to Autism and Beyond.Mechanisms of vascular calcification in CKD-evidence for premature ageing?Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition.Vascular Calcification in Uremia: New-Age Concepts about an Old-Age Problem.Heart failure and kidney dysfunction: epidemiology, mechanisms and management.Klotho, the Holy Grail of the kidney: from salt sensitivity to chronic kidney disease.Klotho Prevents NFκB Translocation and Protects Endothelial Cell From Senescence Induced by Uremia.CDKN2A/p16INK4a expression is associated with vascular progeria in chronic kidney disease.Potential application of klotho in human chronic kidney disease.The FGF23 and Klotho system beyond mineral metabolism.Inflammation and premature aging in advanced chronic kidney disease.Chronic kidney disease: A likely underestimated component of multimorbidity in older patients with chronic obstructive pulmonary disease.The role of epigenetics in renal ageing.αKlotho and Chronic Kidney Disease.Chronic kidney disease and aging: The theme of world kidney day in 2014; nephrologist will become the professional geriatrist.Angiotensin II Type 1 Receptor-Associated Protein Regulates Kidney Aging and Lifespan Independent of Angiotensin.Cellular senescence, senescence-associated secretory phenotype, and chronic kidney diseaseIncreased Telomere Attrition After Renal Transplantation-Impact of Antimetabolite Therapy.Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation.The Effect of Polyphenol-Rich Interventions on Cardiovascular Risk Factors in Haemodialysis: A Systematic Review and Meta-Analysis.Accelerated epigenetic aging and mitochondrial DNA copy number in bipolar disorder.The double-edged sword of endoplasmic reticulum stress in uremic sarcopenia through myogenesis perturbation.
P2860
Q26751527-4994C841-B7B9-46DD-B1F0-95620AD1B84BQ26767479-26DC7BF9-9566-4084-B097-44109B27C6E9Q26783185-76727394-0A68-4869-8784-BFFCA381E229Q26863412-C0B86F92-0A7C-4ECD-BECC-C15CBE8B23F6Q30234466-4647423D-9B2A-4747-9669-39B40E8BCFA0Q30234695-D5E38E9F-AECD-48E9-A542-7DCF987BA7F1Q33579874-0B28EE5A-DB32-4DA0-ABCB-1AED241BFF20Q33783109-A2CE74CD-13C3-43CD-970A-CF3815F908EEQ34292906-1102138D-EB47-4716-85CB-044578D1317EQ34431544-F4F23789-9FEA-4FE2-8DF2-36A73BDD4E19Q35441666-5945A68D-51EC-4CC1-A920-9CB8091D5FA3Q35576122-0DC3E508-5B7A-49F2-83CA-53C679E08222Q35607268-5ABB68E0-D647-4B61-80D3-4D68803463A6Q35871542-0F8671A5-285E-49C9-B6EC-896CC2C6C2BFQ35890086-3617B9C6-8EF6-47E5-A453-6CEF3A5B5F73Q36129776-1F579E99-EA90-4029-9AF9-F884CE438CEDQ36417860-4FA2F6A3-48AA-4D66-89D2-5070371F738AQ37062520-ACAE31C6-284B-4ECB-866B-03DA2228F9A5Q37385781-EB639AA7-9C8C-4115-9BB6-8DD3118D780EQ38135685-FE2030DD-1AA6-4E35-A909-57A0C8214FFEQ38454084-F52C0B35-DDB6-4579-8726-6EF6AEA07F58Q38671493-092C9AE0-184F-49DA-89E0-EEA73BF83F98Q38826590-AA260217-7B8F-407E-A7F3-7B860BA14A39Q38842162-20478452-9EBB-4D7D-8497-6A4577121C3DQ38954111-2350A14E-453B-4EB5-81C2-F7084DED3362Q38964182-F675806C-B31A-45FE-83BD-903727477BAAQ39003568-0C229EA7-4863-462A-B48B-A705953C55C1Q39006777-1B4C43F1-12EF-4478-96E7-BB701EBBA278Q39309490-810524C4-152B-476C-8033-BA9148A08ADCQ39309691-6B7334E8-EAF3-452D-BA7D-336DDF0A85A0Q39381492-88B0061C-DD15-4F50-B8B0-AB3510BDCF36Q39812781-1B1B5105-049E-4205-BD86-B777A5D2A0D0Q40830279-068FF95A-D9B8-4AED-A527-A5C0A12FCA5BQ41628398-E11C6E09-F252-40CE-A64B-98F399D4D841Q42031434-613AA76C-8E6E-4E09-B775-F86C00595990Q42356947-F0132813-4C9C-4F3A-869D-FC3B5F53C03FQ45339625-A40E88F3-DD70-4E61-AF73-782795CBB5E6Q47158647-901B1341-FE73-4D40-8813-34309AC4974DQ47334904-AED27C34-802E-4537-BBDF-268B5804E526Q47642967-2A292AF3-7F7F-460A-B776-6E41675B6A23
P2860
Chronic kidney disease: a clinical model of premature aging.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Chronic kidney disease: a clinical model of premature aging.
@en
type
label
Chronic kidney disease: a clinical model of premature aging.
@en
prefLabel
Chronic kidney disease: a clinical model of premature aging.
@en
P1476
Chronic kidney disease: a clinical model of premature aging.
@en
P2093
Tobias E Larsson
P304
P356
10.1053/J.AJKD.2012.11.051
P577
2013-01-26T00:00:00Z